UHS financials
Universal Health Services, Inc. · end-of-day data as of Oct 16, 2026
Universal Health Services, Inc.
$185.10+19.0%
Hold · 21 analystsPT $205.56 +11.1%
UHS reported revenue of $4.64B for the quarter ended Jun 30, 2026 (Q2 FY2026), up 8.3% from a year earlier. It posted diluted EPS of $5.98, free cash flow of $216M and a net margin of 7.7%.
Valuation
- P/E7.6x
- P/E vs own-7.6%
- P/E vs sector-73.0%
- FCF yield+7.6%
- Market cap$10.91B
Quarterly results
Q2 FY2026: Revenue +8.3% year over year, free cash flow 4.7% of revenue, operating margin 11.1%.
RevenueFree cash flow
| Q2 FY2026 | Jun 30, 2026 | $4.64B | 5.98 | $216M | 90.9% | 11.1% | 7.7% |
| Q1 FY2026 | Mar 31, 2026 | $4.5B | 5.65 | $184M | 90.5% | 11.2% | 7.8% |
| Q4 FY2025 | Dec 31, 2025 | $4.49B | 7.01 | $293M | 90.6% | 11.5% | 9.9% |
| Q3 FY2025 | Sep 30, 2025 | $4.5B | 5.74 | $133M | 90.8% | 11.6% | 8.3% |
| Q2 FY2025 | Jun 30, 2025 | $4.28B | 5.43 | $283M | 90.2% | 11.7% | 8.2% |
| Q1 FY2025 | Mar 31, 2025 | $4.1B | 4.80 | $121M | 90.2% | 11.1% | 7.7% |
| Q4 FY2024 | Dec 31, 2024 | $4.11B | 4.96 | $412M | 90.1% | 11.5% | 8.1% |
| Q3 FY2024 | Sep 30, 2024 | $3.96B | 3.80 | $85.05M | 90.2% | 9.7% | 6.5% |
| Q2 FY2024 | Jun 30, 2024 | $3.91B | 4.26 | $438M | 90.1% | 11.2% | 7.4% |
| Q1 FY2024 | Mar 31, 2024 | $3.84B | 3.82 | $188M | 89.5% | 10.1% | 6.8% |
| Q4 FY2023 | Dec 31, 2023 | $3.7B | 3.16 | $246M | 89.4% | 8.9% | 5.8% |
| Q3 FY2023 | Sep 30, 2023 | $3.56B | 2.40 | -$38.34M | 89.4% | 8.0% | 4.7% |